← Back to Search

Device

MyoVista wavECG for Health Screening

N/A
Waitlist Available
Led By Partho Sengupta, MD
Research Sponsored by Heart Test Laboratories, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Study Summary

This trial is testing a new device that may help detect heart problems. The study will be conducted on subjects who have been enrolled in prior registry studies.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Diagnostic Performance

Trial Design

1Treatment groups
Experimental Treatment
Group I: MyoVista wavECGExperimental Treatment1 Intervention
Single arm - subjects meeting the inclusion, exclusion and screening criteria will receive a MyoVista wavECG and a trans-thoracic echocardiogram.

Find a Location

Who is running the clinical trial?

Heart Test Laboratories, Inc.Lead Sponsor
3 Previous Clinical Trials
975 Total Patients Enrolled
Partho Sengupta, MDPrincipal InvestigatorRutgers Robert Wood Johnson Medical School
4 Previous Clinical Trials
1,398 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are invited to this experiment?

"Affirmative. Data hosted on clinicaltrials.gov affirms that this medical study, initially posted on June 1st 2022, is actively recruiting individuals. Approximately 50 participants must be recruited from a single healthcare facility."

Answered by AI

Are there any openings available for participation in this research?

"Clinicaltrials.gov reveals that this research is actively recruiting participants, with the trial having been initiated on June 1st 2022 and amended most recently on August 1st of the same year."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What site did they apply to?
University of Texas Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
~18 spots leftby Mar 2025